Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Dysphagia is associated with presynaptic dopaminergic dysfunction and greater non-motor symptom burden in early drug-naïve Parkinson's patients.

Polychronis S, Dervenoulas G, Yousaf T, Niccolini F, Pagano G, Politis M.

PLoS One. 2019 Jul 25;14(7):e0214352. doi: 10.1371/journal.pone.0214352. eCollection 2019.

2.

Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.

Wilson H, Dervenoulas G, Pagano G, Koros C, Yousaf T, Picillo M, Polychronis S, Simitsi A, Giordano B, Chappell Z, Corcoran B, Stamelou M, Gunn RN, Pellecchia MT, Rabiner EA, Barone P, Stefanis L, Politis M.

Lancet Neurol. 2019 Aug;18(8):748-759. doi: 10.1016/S1474-4422(19)30140-1. Epub 2019 Jun 19.

PMID:
31229470
3.

Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson's disease.

Pagano G, Niccolini F, Wilson H, Yousaf T, Khan NL, Martino D, Plisson C, Gunn RN, Rabiner EA, Piccini P, Foltynie T, Politis M.

Mov Disord. 2019 Jun 3. doi: 10.1002/mds.27733. [Epub ahead of print]

PMID:
31158314
4.

Speech difficulties in early de novo patients with Parkinson's disease.

Polychronis S, Niccolini F, Pagano G, Yousaf T, Politis M.

Parkinsonism Relat Disord. 2019 May 7. pii: S1353-8020(19)30221-4. doi: 10.1016/j.parkreldis.2019.04.026. [Epub ahead of print]

PMID:
31078401
5.

The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease.

Wilson H, Pagano G, Niccolini F, Muhlert N, Mehta MA, Searle G, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Parkinsonism Relat Disord. 2019 Feb 22. pii: S1353-8020(19)30073-2. doi: 10.1016/j.parkreldis.2019.02.027. [Epub ahead of print]

PMID:
30824285
6.

Predicting cognitive decline with non-clinical markers in Parkinson's disease (PRECODE-2).

Yousaf T, Pagano G, Niccolini F, Politis M.

J Neurol. 2019 May;266(5):1203-1210. doi: 10.1007/s00415-019-09250-y. Epub 2019 Feb 28.

7.

Dementia spectrum disorders: lessons learnt from decades with PET research.

Wilson H, Pagano G, Politis M.

J Neural Transm (Vienna). 2019 Mar;126(3):233-251. doi: 10.1007/s00702-019-01975-4. Epub 2019 Feb 14. Review.

8.

Cortical thinning across Parkinson's disease stages and clinical correlates.

Wilson H, Niccolini F, Pellicano C, Politis M.

J Neurol Sci. 2019 Mar 15;398:31-38. doi: 10.1016/j.jns.2019.01.020. Epub 2019 Jan 17.

PMID:
30682518
9.

Preface.

Politis M.

Int Rev Neurobiol. 2019;144:xiii. doi: 10.1016/S0074-7742(19)30009-1. No abstract available.

PMID:
30638459
10.

Molecular Imaging of Dementia With Lewy Bodies.

Cousins O, Yousaf T, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2019;144:59-93. doi: 10.1016/bs.irn.2018.10.007. Epub 2018 Nov 28.

PMID:
30638457
11.

Hybrid PET-MRI Applications in Movement Disorders.

Tondo G, Esposito M, Dervenoulas G, Wilson H, Politis M, Pagano G.

Int Rev Neurobiol. 2019;144:211-257. doi: 10.1016/bs.irn.2018.10.003. Epub 2018 Nov 8.

PMID:
30638455
12.

Imaging Markers of Progression in Parkinson's Disease.

Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S; IPMDS‐Neuroimaging Study Group.

Mov Disord Clin Pract. 2018 Oct 9;5(6):586-596. doi: 10.1002/mdc3.12673. eCollection 2018 Nov-Dec. Review.

PMID:
30637278
13.

Preface.

Politis M.

Int Rev Neurobiol. 2018;143:ix-x. doi: 10.1016/S0074-7742(18)30162-4. No abstract available.

PMID:
30473199
14.

Imaging Transplantation in Movement Disorders.

de Natale ER, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2018;143:213-263. doi: 10.1016/bs.irn.2018.10.002. Epub 2018 Nov 3. Review.

PMID:
30473196
15.

Preface.

Politis M.

Int Rev Neurobiol. 2018;142:xi-xii. doi: 10.1016/S0074-7742(18)30146-6. No abstract available.

PMID:
30409262
16.

Structural Magnetic Resonance Imaging in Huntington's Disease.

Wilson H, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;142:335-380. doi: 10.1016/bs.irn.2018.09.006. Epub 2018 Oct 8. Review.

PMID:
30409258
17.

Molecular Imaging in Huntington's Disease.

Wilson H, Politis M.

Int Rev Neurobiol. 2018;142:289-333. doi: 10.1016/bs.irn.2018.08.007. Epub 2018 Aug 29. Review.

PMID:
30409256
18.

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Dec;33(12):1961-1965. doi: 10.1002/mds.27523. Epub 2018 Oct 21.

PMID:
30345538
19.

Neuroimaging of Sleep Disturbances in Movement Disorders.

Yousaf T, Pagano G, Wilson H, Politis M.

Front Neurol. 2018 Sep 11;9:767. doi: 10.3389/fneur.2018.00767. eCollection 2018. Review.

20.

Preface.

Politis M.

Int Rev Neurobiol. 2018;141:xv-xvi. doi: 10.1016/S0074-7742(18)30122-3. No abstract available.

PMID:
30314609
21.

Advances in MRI Methodology.

Yousaf T, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;141:31-76. doi: 10.1016/bs.irn.2018.08.008. Epub 2018 Sep 14. Review.

PMID:
30314602
22.

Molecular Imaging of the Serotonergic System in Parkinson's Disease.

Pagano G, Politis M.

Int Rev Neurobiol. 2018;141:173-210. doi: 10.1016/bs.irn.2018.08.002. Epub 2018 Sep 6. Review.

PMID:
30314596
23.

Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

de Natale ER, Niccolini F, Wilson H, Politis M.

Int Rev Neurobiol. 2018;141:131-172. doi: 10.1016/bs.irn.2018.08.003. Epub 2018 Sep 6. Review.

PMID:
30314595
24.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2019 Jun;266(6):1293-1302. doi: 10.1007/s00415-018-9016-3. Epub 2018 Aug 17. Review.

25.

Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.

26.

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M.

Neurology. 2018 Sep 4;91(10):e894-e905. doi: 10.1212/WNL.0000000000006134. Epub 2018 Aug 8.

PMID:
30089615
27.

Proton Collision on Deoxyribose Originating from Doubly Ionized Water Molecule Dissociation.

Hervé du Penhoat MA, Moraga NRG, Gaigeot MP, Vuilleumier R, Tavernelli I, Politis MF.

J Phys Chem A. 2018 Jun 21;122(24):5311-5320. doi: 10.1021/acs.jpca.8b04787. Epub 2018 Jun 11.

PMID:
29846073
28.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

29.

Neuroimaging in Lewy body dementia.

Yousaf T, Dervenoulas G, Valkimadi PE, Politis M.

J Neurol. 2019 Jan;266(1):1-26. doi: 10.1007/s00415-018-8892-x. Epub 2018 May 14. Review.

30.

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.

Schulz J, Pagano G, Fernández Bonfante JA, Wilson H, Politis M.

Brain. 2018 May 1;141(5):1501-1516. doi: 10.1093/brain/awy072.

31.

Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Nørgaard M, Ganz M, Svarer C, Feng L, Ichise M, Lanzenberger R, Lubberink M, Parsey RV, Politis M, Rabiner EA, Slifstein M, Sossi V, Suhara T, Talbot PS, Turkheimer F, Strother SC, Knudsen GM.

J Cereb Blood Flow Metab. 2019 Feb;39(2):210-222. doi: 10.1177/0271678X18770107. Epub 2018 Apr 13.

PMID:
29651896
32.

Diabetes mellitus and Parkinson disease.

Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M.

Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.

PMID:
29626177
33.

Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.

Yousaf T, Pagano G, Niccolini F, Politis M.

J Neurol Sci. 2018 Apr 15;387:220-227. doi: 10.1016/j.jns.2018.02.032. Epub 2018 Feb 21.

PMID:
29571867
34.

Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness.

Yousaf T, Pagano G, Niccolini F, Politis M.

Sleep Med. 2018 Mar;43:25-30. doi: 10.1016/j.sleep.2017.11.1137. Epub 2017 Dec 12.

PMID:
29482807
35.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
36.

Roles of Hydration for Inducing Decomposition of 2-Deoxy-d-ribose by Ionization of Oxygen K-Shell Electrons.

Fujii K, Izumi Y, Narita A, Ghose KK, López-Tarifa P, Touati A, Spezia R, Vuilleumier R, Gaigeot MP, Politis MF, Du Penhoat MH, Yokoya A.

Radiat Res. 2018 Mar;189(3):264-272. doi: 10.1667/RR14225.1. Epub 2018 Jan 8.

PMID:
29309265
37.

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.

Pagano G, Niccolini F, Politis M.

J Neural Transm (Vienna). 2018 Aug;125(8):1217-1223. doi: 10.1007/s00702-017-1823-7. Epub 2017 Dec 20. Review.

38.

Be vigilant for dementia in Parkinson’s disease.

Niccolini F, Diamantopoulos K, Kiosses S, Politis M.

Practitioner. 2017 May;261(1804):11-5. Review.

PMID:
29120562
39.

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2018 Jan;33(1):117-127. doi: 10.1002/mds.27183. Epub 2017 Oct 30.

40.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
41.

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.

Pagano G, Yousaf T, Politis M.

Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2. Review.

42.

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.

Niccolini F, Pagano G, Fusar-Poli P, Wood A, Mrzljak L, Sampaio C, Politis M.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):185-196. doi: 10.1136/jnnp-2017-316633. Epub 2017 Sep 9.

PMID:
28889093
43.

Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.

Politis M, Wilson H, Wu K, Brooks DJ, Piccini P.

Neuroimage Clin. 2017 Aug 24;16:455-460. doi: 10.1016/j.nicl.2017.08.013. eCollection 2017.

44.

Imaging the Nonmotor Symptoms in Parkinson's Disease.

Yousaf T, Wilson H, Politis M.

Int Rev Neurobiol. 2017;133:179-257. doi: 10.1016/bs.irn.2017.05.001. Epub 2017 Jun 7. Review.

PMID:
28802921
45.

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease.

Moonga I, Niccolini F, Wilson H, Pagano G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Eur J Neurol. 2017 Sep;24(9):1173-1182. doi: 10.1111/ene.13374. Epub 2017 Jul 28.

PMID:
28752644
46.

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.

Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Neurology. 2017 Aug 8;89(6):586-593. doi: 10.1212/WNL.0000000000004201. Epub 2017 Jul 12.

PMID:
28701494
47.

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Qamar MA, Sauerbier A, Politis M, Carr H, Loehrer P, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Jan 25;3:5. doi: 10.1038/s41531-016-0006-9. eCollection 2017.

48.

PET image reconstruction using multi-parametric anato-functional priors.

Mehranian A, Belzunce MA, Niccolini F, Politis M, Prieto C, Turkheimer F, Hammers A, Reader AJ.

Phys Med Biol. 2017 Jul 6;62(15):5975-6007. doi: 10.1088/1361-6560/aa7670.

PMID:
28570263
49.

Imaging in Parkinson's Disease.

Politis M, Pagano G, Niccolini F.

Int Rev Neurobiol. 2017;132:233-274. doi: 10.1016/bs.irn.2017.02.015. Epub 2017 Mar 30. Review.

PMID:
28554409
50.

Disease progression in LRRK2 parkinsonism.

Politis M.

Lancet Neurol. 2017 May;16(5):334-335. doi: 10.1016/S1474-4422(17)30082-0. No abstract available.

PMID:
28414642

Supplemental Content

Loading ...
Support Center